Literature DB >> 10857774

Immunoexpression of tumour necrosis factor-alpha and its receptors 1 and 2 correlates with proliferation/apoptosis equilibrium in normal, hyperplasic and carcinomatous human prostate.

M P de Miguel1, M Royuela, F R Bethencourt, L Santamaría, B Fraile, R Paniagua.   

Abstract

Immunohistochemical and semiquantitative study of TNF-alpha, its receptors types 1 (TNFR1) and 2 (TNFR2), cell proliferation (Ki-67 nuclear antigen), and apoptosis (Tunel method) was carried out in human prostates, in normal healthy conditions, as well as in benign prostatic hyperplasia (BPH) and prostatic carcinoma (PC). Cell proliferation was higher in BPH than in normal prostates, and even higher in PC, mainly in neoformations showing a microglandular pattern. The apoptotic index was similar in BPH and normal prostates, and increased significantly in PC with independence of the pattern. In BPH, immunoreaction to TNF-alpha decreased as compared with that of normal prostates, while immunoreactions to both TNF-alpha receptors increased. This suggests a feedback downregulation of the factor, and that the low TNF-alpha activity in BPH are compensated by the increased amount of receptors. In PC, immunoreaction to TNF-alpha and its two receptors increased markedly, suggesting that the TNF-induced effects are also increased. Contrarily to cell proliferation immunoexpression, PC reaction to TNFR2 was stronger in the papillar pattern than in the micrograndular pattern, and this suggests an inverse correlation between TNFR2 expression and cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10857774     DOI: 10.1006/cyto.1999.0585

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  13 in total

1.  Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms--action of two new agents.

Authors:  Rajeev Kumar; Vikas Verma; Amit Sarswat; J P Maikhuri; Ashish Jain; Rajeev K Jain; V L Sharma; Diwakar Dalela; Gopal Gupta
Journal:  Invest New Drugs       Date:  2010-12-23       Impact factor: 3.850

2.  Interleukin-6: a potential biomarker of resistance to multitargeted receptor tyrosine kinase inhibitors in castration-resistant prostate cancer.

Authors:  Alexander Kutikov; Peter Makhov; Konstantin Golovine; Daniel J Canter; Mohit Sirohi; Ryan Street; Jay Simhan; Robert G Uzzo; Vladimir M Kolenko
Journal:  Urology       Date:  2011-10       Impact factor: 2.649

3.  Correlation of p21 gene codon 31 polymorphism and TNF-alpha gene polymorphism with nasopharyngeal carcinoma.

Authors:  Ming-Hsui Tsai; Wen-Chi Chen; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

Review 4.  Roles of K+ channels in regulating tumour cell proliferation and apoptosis.

Authors:  Zhiguo Wang
Journal:  Pflugers Arch       Date:  2004-03-27       Impact factor: 3.657

5.  MAP Kinases and Prostate Cancer.

Authors:  Gonzalo Rodríguez-Berriguete; Benito Fraile; Pilar Martínez-Onsurbe; Gabriel Olmedilla; Ricardo Paniagua; Mar Royuela
Journal:  J Signal Transduct       Date:  2011-10-20

6.  Proinflammatory cytokines in prostate cancer development and progression promoted by high-fat diet.

Authors:  Hua Xu; Meng-bo Hu; Pei-de Bai; Wen-hui Zhu; Sheng-hua Liu; Jun-yao Hou; Zu-quan Xiong; Qiang Ding; Hao-wen Jiang
Journal:  Biomed Res Int       Date:  2015-02-04       Impact factor: 3.411

7.  Role of IAPs in prostate cancer progression: immunohistochemical study in normal and pathological (benign hyperplastic, prostatic intraepithelial neoplasia and cancer) human prostate.

Authors:  Gonzalo Rodríguez-Berriguete; Benito Fraile; Fermín R de Bethencourt; Angela Prieto-Folgado; Nahikari Bartolome; Claudia Nuñez; Bruna Prati; Pilar Martínez-Onsurbe; Gabriel Olmedilla; Ricardo Paniagua; Mar Royuela
Journal:  BMC Cancer       Date:  2010-01-15       Impact factor: 4.430

8.  Dissecting Major Signaling Pathways throughout the Development of Prostate Cancer.

Authors:  Henrique B da Silva; Eduardo P Amaral; Eduardo L Nolasco; Nathalia C de Victo; Rodrigo Atique; Carina C Jank; Valesca Anschau; Luiz F Zerbini; Ricardo G Correa
Journal:  Prostate Cancer       Date:  2013-04-29

9.  Paradoxical roles of tumour necrosis factor-alpha in prostate cancer biology.

Authors:  Brian W C Tse; Kieran F Scott; Pamela J Russell
Journal:  Prostate Cancer       Date:  2012-12-27

10.  Significance of TNF-α and the Adhesion Molecules: L-Selectin and VCAM-1 in Papillary Thyroid Carcinoma.

Authors:  Toral P Kobawala; Trupti I Trivedi; Kinjal K Gajjar; Darshita H Patel; Girish H Patel; Nandita R Ghosh
Journal:  J Thyroid Res       Date:  2016-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.